Practice Areas - Debt Capital Markets Law Firms and Lawyers
Deal Date: | 09-12-2015 | Practice Area: | Debt Capital Markets |
Deal Title: | Mylan NV Rule 144A/Reg S Registered Debt Offering | Industry: | Pharmaceuticals & Biotechnology |
Description: |
Cravath represented Mylan NV in connection with its USD1 billion Rule 144A/Reg. S investment grade senior debt offering. Mylan NV is a leading global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The notes were listed on the Irish Stock Exchange. The transaction closed on December 9, 2015.
|
||
Financial Center: | New York | Value: | 500.01-1000.00 |
Advised Party: | Issuer | Law Firm | Cravath |
Issuer Jurisdiction | United States | Listing Jurisdiction | United States |
Classification: |
Corporate Bonds Senior Debt |
Lawyer | William V Fogg |